Emergency Number

Investors

  •  Dr. Vikram Shah – Chairman & Managing Director, Shalby Limited at Edelweiss India Conference (Feb’18):

 

  • Dr. Vikram Shah – Chairman & Managing Director, Shalby Limited at IIFL Enterprising India IX-2018 (Feb’18):

Disclosure under SEBI PIT Reg. 7(2)

Announcement – Dr. Purvish Parikh as -Group Advisor

Press Release – Radiation Therapy Centre, Jaipur

Press Release – Radiation Therapy Centre, Naroda, Ahmedabad

Authorization to KMP under Reg. 30 of SEBI LODR

Statement of Investors Complaints – Q3 FY 2017-18

Disclosure under SEBI PIT Reg. 7(2)

Utilization of Issue Proceeds – Q3 FY 2017-18

Intimation about Loss of Share certificates

Press Release – MoU with with Gleneagles Global Health City for Heart & Lung Transplants Program

Statement of Investor Complaints – Q4 FY 2017-18

Share Capital Audit – 31-03-2018

Compliance Certificate under Reg. 7(3) of LODR

Press Release – MoU with Sen Sok Intl Hospital, Cambodia

Certificate under Regulation 40(10) of SEBI LODR

Joint Replacement Surgeries under Mukhyamantri Amrutam Yojana

Change in CIN

Schedule of Investor / Analyst Meet

Schedule of Investor / Analyst Meet – 27-04-2018

Utilization of Issue Proceeds – Q4 FY 2017-18

Utilization of Issue Proceeds – Q4 FY 2017-18

Intimation Conference Call

Intimation Appointment of CDSL as designated depository

Collaboration with Berkeley Health Education

Investor/Analyst meeting with Motilal Oswal Securities Limited

Investors meet/UBS India- Midcap conference

Resignation of Chief Executive Officer of the Company

Intimation Analyst meet HDFC Securities 26-06-2018

Updates relating to resignation of CEO

Man of the Year Award – Dr. Vikram Shah

Intimation Analyst meet – 26-06-2018

Intimation Analyst meet – 27-06-2018

Intimation Analyst meet – 02-07-2018

Intimation Analyst meet – 06-07-2018

Intimation Liver Disease and Transplantation

Karvy Reconciliation Report

Investor Grievance report

Utilization of Issue Proceeds – Q1 FY 2018-19

 Intimation of AGM

 Intimation of Book closure

 AGM Notice & Annual Report 2017-18

 Newspaper Ad. AGM, Book closure & E-voting

 Outcome of AGM

 Voting Results

 

Registered & Corporate Office

Shalby Limited

Opposite Karnawati Club,

Sarkhej Gandhinagar Highway,

Near Prahlad Nagar Garden,

Ahmedabad – 380 015, Gujarat, India

Phone: +91 79 4020 3000

Fax :+91 79 4020 3120

CIN : L85110GJ2004PLC044667

 

Listed at NSE & BSE

Listing Date    December 15, 2017

Scrip Code : NSE – SHALBY

BSE – 540797

 

ISIN     INE597J01018

Face Value of Shares  ` 10

Outstanding Shares 108,009,770

Financial Year ending  March 31 of every year

Grievance Redressal

The Shareholders may forward their queries/grievances to the Company at the following address :

Compliance Officer :

Mr. Jayesh Patel

Company Secretary and Compliance Officer

Email : Companysecretary@shalby.in

Tel. No : +91 79 4020 3000

Fax No : +91 79 4020 3120

Website : www.shalby.org

Registrar & Transfer Agent

Karvy Computershare Private Limited

Unit : Shalby Limited

Karvy Selenium, Tower B,

Plot 31 – 32, Gacchibowli

Financial District, Nanakramguda,

Hyderabad – 500 032, Telangana, India

Tel: +91 40 6716 2222

Fax: +91 40 2343 1551

Investor Grievance E-mail: einward.ris@karvy.com

News paper Ad – ET A’bad (Eng + Guj)

Financial Year Q1 Q2 Q3 Q4
Result Transcript Result Transcript Result Transcript Result Transcript
2017-18
2018-19

 

 

Financial Year Q1 Q2 Q3 Q4
2017-18
2018-19
Financial Year Q1 Q2 Q3 Q4
2017-18  
2018-19
Annual Reports
2016-17 2017-18
Shalby Limited
Subsidiary Companies
Shalby (Kenya) Limited
Yogeshwar Healthcare Ltd.
Vrundavan Shalby Hospitals Ltd.
Shalby International Ltd.
Griffin Mediquip LLP